DG
DGNOF.US DIAGNOS Inc
- Market cap
- USD 27.8M
- P/E
- -
- P/B
- 59.37x
- ROE
- -663.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is DGNOF.US undervalued?
Graham numberThe Graham number of DIAGNOS Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
DIAGNOS Inc fundamental analysis
No fundamental analysis for DIAGNOS Inc yet.
DIAGNOS Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About DIAGNOS Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields o…
Full company profileDIAGNOS Inc financial statements
DIAGNOS Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.39M | 1.61M | 326K | 332K | 267K | 439K | 486K | 170K | 104K | 65.5K |
| Gross Profit | 719K | 291K | -759K | -473K | -348K | -418K | -307K | -838K | 50.1K | 10.0K |
| Operating Income | -1.97M | -2.47M | -2.93M | -2.80M | -2.28M | -2.66M | -2.22M | -2.59M | -3.81M | -4.25M |
| EBITDA | - | -2.03M | -2.69M | -2.93M | -1.93M | -2.45M | -2.10M | -2.45M | -3.56M | -4.04M |
| Net Income | -5.42M | -2.90M | -3.84M | -3.38M | -2.05M | -2.61M | -2.48M | -3.12M | -4.29M | -4.56M |
| EPS | -0.36 | -0.17 | -0.18 | -0.06 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| Balance Sheet | ||||||||||
| Total Assets | 1.31M | 1.52M | 1.21M | 2.43M | 1.95M | 1.54M | 823K | 664K | 3.64M | 2.39M |
| Total Liabilities | 6.88M | 5.16M | 6.29M | 615K | 818K | 1.66M | 2.77M | 3.72M | 3.40M | 1.70M |
| Shareholders' Equity | -5.58M | -3.64M | -5.08M | 1.82M | 1.13M | -114K | -1.95M | -3.05M | 233K | 687K |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 570K | 359K | 421K | 297K | 219K | 88.7K | 310K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -1.79M | -2.24M | -2.32M | -2.64M | -1.36M | -2.04M | -1.88M | -2.15M | -3.64M | -3.75M |
| Capital Expenditure | 233K | 271K | 42.3K | 15.1K | 42.2K | 31.0K | 24.2K | 10.9K | 13.7K | 11.1K |
| Free Cash Flow | - | -2.51M | -2.36M | -2.66M | -1.40M | -2.07M | -1.91M | -2.16M | -3.65M | -3.76M |
| Ratios | ||||||||||
| ROE | - | - | - | -186.0% | -181.2% | - | - | - | -1,838.8% | -663.2% |
| ROA | -414.0% | -190.1% | -318.0% | -139.0% | -105.2% | -169.2% | -301.4% | -470.1% | -117.9% | -190.6% |
| Net Profit Margin | -226.8% | -179.6% | -1,175.9% | -1,020.4% | -768.1% | -594.4% | -510.7% | -1,833.9% | -4,129.6% | -6,956.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
DIAGNOS Inc dividends
DIAGNOS Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10 on Apr 24, 2019.
Who owns DIAGNOS Inc
- Insiders 5.41%
- Institutions 0.00%
- Public & others 94.59%
- Shares outstanding 121M
- Free float 114M
DIAGNOS Inc company profile
- Company name
- DIAGNOS Inc
- Ticker
- DGNOF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- March
- Address
- 7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7
- Phone
- 450 678 8882
- Website
- diagnosmedical.com
About DIAGNOS Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
DIAGNOS Inc management
5- Mr. Andre LarenteCEO, President & Executive Director
- Mr. Marc-Andre Massue CA, CPAVP of Finance, CFO & Secretary
- Mr. Yves-Stephane CoutureChief Operating Officer
- Dr. Hadi Chakor DjelthiaChief Medical Officer
- Dr. Ismail Ben AyedChief Artificial Intelligence Scientist